NCT05298423 · Interventional trial
Study of Pembrolizumab/Vibostolimab (MK-7684A) in Combination With Concurrent Chemoradiotherapy Followed by Pembrolizumab/Vibostolimab Versus Concurrent Chemoradiotherapy Followed by Durvalumab in Participants With Stage III Non-small Cell Lung Cancer (MK-7684A-006)
Overall registry status Completed
Phase 3
Conditions Carcinoma, Non-Small-Cell Lung
Delaware Valley sites
- Thomas Jefferson University - Clinical Research Institute ( Site 2813) · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory